REFERENCES
- Vollrath B, Weir BK, Macdonald RL, et al. Intracellular mechan-isms involved in the responses of cerebrovascular smooth muscle cells to hemoglobin. ] Neurosurg 1994; 80: 261–268
- Cappelletto B, Caner HH. Attenuation of vasospasm and hemo-globin-induced constriction in the rabbit basilar artery by a novel protease inhibitor. Neurosurg Focus 1997; 3: e2
- Dietrich HH, Dacey RG, Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000; 46: 517–530
- Brink PR, Ricotta J. Biophysical characteristics of gap junctions in vascular wall cells: Implications for vascular biology and disease. Braz J Med Biol Res 2000; 33: 415–422
- de Wit C. Connexins pave the way for vascular communication. News Physiol Sci 2004; 19: 148–153
- Wit C, Wolfle SE. Connexin-dependent communication within the vascular wall: Contribution to the control of arteriolar diameter. Adv Cardiol 2006; 42: 268–283
- Haefligera JA, Nicoda P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004; 62: 345–356
- Haddock RE, Grayson TH. Endothelial coordination of cerebral vasomotion via myoendothelial gap junctions containing connex-ins 37 and 40. Am] Physiol Heart Circ Physiol 2006; 291: H2036—H2038
- Lagaud G, Karicheti V. Blockers of gap junctions attenuate myogenic tone in cerebral arteries. Am I Physiol 2002; 283: H2177—H2186
- Sagar GD, Larson DM. Carbenoxolone inhibits junctional transfer and upregulates Connexin43 expression by a protein kinase A-dependent pathway. I Cell Biochem 2006; 98: 1543–1551
- Goto K, Fujii K. Critical role of gap junctions in endothelium-dependent hyperpolarization in rat mesenteric arteries. Clin Exp Pharmacol Physiol 2002; 29: 595–602
- Bostanci MO, Bagirici F. Anticonvulsive effects of carbenoxolone on penicillin-induced epileptiform activity: An in vivo study. Neuropharmacology 52: 362-367
- Bostanci MO, Baqirici F. The effects of octanol on penicillin induced epileptiform activity in rats: An in vivo study. Epilepsy Res 2006; 71: 188–194
- Margineanu DG, Klitgaard H. Can gap-junction blockade prefer-entially inhibit neuronal hypersynchrony vs. excitability? Neuropharmacology 2001; 41: 377–383
- Ryan MJ, Liu B, Herbowy MT, et al. Intercellular communication between rennin expressing As4.1 cells, endothelial cells and smooth muscle cells. Life Sci 2003; 72: 1289–1301
- Leite R, Webb RC. Increased dilator response to heptanol and octanol in aorta from DOCA-salt-hypertensive rats. Pharmacology 2001; 62: 29–35
- Zhou C, Yamaguchi M, Kusaka G, et al. Caspase blockers prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. I Cereb Blood Flow Metab 2004; 24: 419–431
- Rozental R. Gap junctions in the cardiovascular and immune systems. Braz J Med Biol Res 2000; 33: 365–368
- Oviedo-Orta E, Howard EW. Gap junctions and connexin-mediated communication in the immune system. Biochim Biophys Acta 2004; 1662: 102–112
- Vancheri C, Mastruzzo C. Normal human lung fibroblasts differently modulate interleukin-10 and interleukin-12 production by monocytes: Implications for an altered immune response in pulmonary chronic inflammation. Am] Respir Cell Mol Biol 2001; 25: 592–599
- Nerve JC, Dhein S. Pharmacology of cardiovascular gap junctions. Adv Cardiol 2006; 42: 107–131
- Segal SS. Integration of blood flow control to skeletal muscle: Key role of feed arteries. Acta Physiol Scand 2000; 168: 511–518
- Beny JL. Information networks in the arterial wall. News Physiol Sci 1999; 14: 68–73
- Christ GJ, Spray DC. Gap junctions in vascular tissues: Evaluating the role of intercellular communication in the modulation of vasomotor tone. Circ Res 1996; 79: 631–646
- Haefliger JA, Meda P. Chronic hypertension alters the expression of Cx43 in cardiovascular muscle cells. Braz J Med Biol Res 2000; 33: 431–438
- Liao Y, Day KH, Damon DN. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA 2001; 98: 9989–9994
- Watts SW, Webb RC. Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension. Hypertension 1996; 28: 888–893